Global Biopharmaceutical CMO Market Report 2024

Biopharmaceutical CMO Global Market Report 2023 – By Product (Biologics, Biosimilars), By Source (Mammalian, Non-Mammalian), By Service (Manufacturing, Fill And Finish Operations, Analytical And QC Studies, Packaging) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Biopharmaceutical CMO Market

Proud Members Of

checkslacipN checkaoirsN checkscipN

Biopharmaceutical CMO is a business that provides manufacturing services, with the capacity to produce small quantities for preclinical research and development and more significant numbers needed for clinical trials and commercialization. The biopharmaceutical CMO assists in lowering overall operational risk and time to market.

The main types of biopharmaceutical CMO products includes biologics and biosimilars. The biologics are used to produce a wide range of products derived from human, animal, or microbial sources as biologic medications. Biologics are substance made from living things or contains some components of them. Vaccines, blood, blood components, cells, allergies, genes, tissues, and recombinant proteins are some of the biologic medications. The biopharmaceutical CMO products comes from various sources including mammalian and non-mammalian. The biopharmaceutical CMO services includes manufacturing, fill and finish operations, analytical and qc studies, and packaging.

The global biopharmaceutical CMO market is segmented -

1) By Product: Biologics, Biosimilars

2) By Source: Mammalian, Non-Mammalian

3) By Service: Manufacturing, Fill And Finish Operations, Analytical And QC Studies, Packaging

The global biopharmaceutical cmo market size grew from $18.74 billion in 2022 to $21.51 billion in 2023 at a compound annual growth rate (CAGR) of 14.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global biopharmaceutical cmo is expected to grow to $34.55 billion in 2027 at a CAGR of 12.6%.

An increase in the robustness of venture capital investments for the life science sector is expected to propel the growth of the biopharmaceutical CMO market. The life sciences sector refers to the businesses and organizations that conduct research and development on living beings. The robustness of venture capital investments is a feature describing the capacity of a model, test, or system to function correctly when its parameters or presumptions are changed. As the investment in the life science sector increases, there will be an increase in the manufacturing of biopharmaceuticals. For instance, in September 2021, according to JLL, a US-based company specializing in investment consultancy, the record amount of venture capital was raised in the UK over the last three months, with £1.9 billion raised between 1 June and 26 August 2021. This incredible investment brings the UK total for 2021 to £4.25 billion ($5.787 billion) YTD, up from £2.8 billion in 2020. Therefore, an increase in the robustness of venture capital investments for the life science sector is driving the biopharmaceutical CMO market growth.

Major players in the biopharmaceutical CMO market are Lonza Group AG, Fujifilm Diosynth Biotechnologies U.S.A., Inc., Thermo Fisher Scientific, Inc., Samsung BioLogics, WuXi Biologics, Siegfried Holding AG, Catalent, Inc., Cambrex Corporation, Binex Co., Ltd., Rentschler Biotechnologies GmbH, Inno Biologics SdnBhd, Boehringer Ingelheim GmbH, JRS Pharma, AGC Biologics, ProBioGen AG, and Biomeva GmbH.

Technological advancement is a key trend gaining popularity in the biopharmaceutical CMO market. Major companies in the biopharmaceutical CMO market are advancing in their new technologies and research and development using Iot. The Internet of Things (IoT) refers to the application of networked sensors and actuators to regulate and observe the environment, the objects that move within it, and the people who act within it. A vast amount of data can be produced by sensors, actuators, and other components integrated into manufacturing machinery and networked computer systems. The data can be analysed for insights and opportunities to increase production efficiency, automate monitoring and controlling tasks, and enable adaptable manufacturing systems. For instance, in February 2022, M2Cloud, a Korea-based bio-cold chain technology company, along with Thales, a France-based company specialising in IoT communication modules, developed an IoT-based LTE monitoring system for biopharmaceutical monitoring. It is helpful in the real-time monitoring of freezers, refrigerated warehouses, etc., along with tracking the delivery boxes being delivered in real-time. It can remotely verify temperature and position information in real time by just turning on the power. With technologies designed for biopharmaceutical management, it increases the safety of pharmaceutical products.

In July 2021, AstraZeneca, a UK-based biopharmaceutical business that develops innovative medicines, acquired Alexion Pharmaceuticals, Inc for an undisclosed amount. Through this acquisition, AstraZeneca will manufacture medicines for rare diseases. AstraZeneca now has a more robust scientific presence in immunology because of Alexion's complement-biology platform and substantial pipeline. Alexion Pharmaceuticals, Inc is a USA-based biopharmaceutical company focused on developing drugs and therapeis for people living with rare disorders.

North America was the largest region in the biopharmaceutical CMO market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical CMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the biopharmaceutical CMO market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The biopharmaceutical CMO market includes revenues earned by entities by process development. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The biopharmaceutical CMO market research report is one of a series of new reports from The Business Research Company that provides biopharmaceutical CMO market statistics, including biopharmaceutical CMO industry global market size, regional shares, competitors with a biopharmaceutical CMO market share, detailed biopharmaceutical CMO market segments, market trends and opportunities, and any further data you may need to thrive in the biopharmaceutical CMO industry. This biopharmaceutical CMO market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. Biopharmaceutical CMO Market Characteristics

    3. Biopharmaceutical CMO Market Trends And Strategies

    4. Biopharmaceutical CMO Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Biopharmaceutical CMO Market

    4.2. Ukraine-Russia War Impact On Biopharmaceutical CMO Market

    4.3. Impact Of High Inflation On Biopharmaceutical CMO Market

    5. Biopharmaceutical CMO Market Size And Growth

    5.1. Global Biopharmaceutical CMO Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Biopharmaceutical CMO Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Biopharmaceutical CMO Market Segmentation

    6.1. Global Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Biologics

    Biosimilars

    6.2. Global Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Mammalian

    Non-Mammalian

    6.3. Global Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Manufacturing

    Fill And Finish Operations

    Analytical And QC Studies

    Packaging

    7. Biopharmaceutical CMO Market Regional And Country Analysis

    7.1. Global Biopharmaceutical CMO Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Biopharmaceutical CMO Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Biopharmaceutical CMO Market

    8.1. Asia-Pacific Biopharmaceutical CMO Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Biopharmaceutical CMO Market

    9.1. China Biopharmaceutical CMO Market Overview

    9.2. China Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Biopharmaceutical CMO Market

    10.1. India Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Biopharmaceutical CMO Market

    11.1. Japan Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Biopharmaceutical CMO Market

    12.1. Australia Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Biopharmaceutical CMO Market

    13.1. Indonesia Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Biopharmaceutical CMO Market

    14.1. South Korea Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Biopharmaceutical CMO Market

    15.1. Western Europe Biopharmaceutical CMO Market Overview

    15.2. Western Europe Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Biopharmaceutical CMO Market

    16.1. UK Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Biopharmaceutical CMO Market

    17.1. Germany Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Biopharmaceutical CMO Market

    18.4. France Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Biopharmaceutical CMO Market

    19.1. Eastern Europe Biopharmaceutical CMO Market Overview

    19.2. Eastern Europe Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Biopharmaceutical CMO Market

    20.1. Russia Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Biopharmaceutical CMO Market

    21.1. North America Biopharmaceutical CMO Market Overview

    21.2. North America Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Biopharmaceutical CMO Market

    22.1. USA Biopharmaceutical CMO Market Overview

    22.2. USA Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Biopharmaceutical CMO Market

    23.1. South America Biopharmaceutical CMO Market Overview

    23.2. South America Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Biopharmaceutical CMO Market

    24.1. Brazil Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Biopharmaceutical CMO Market

    25.1. Middle East Biopharmaceutical CMO Market Overview

    25.2. Middle East Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Biopharmaceutical CMO Market

    26.1. Africa Biopharmaceutical CMO Market Overview

    26.2. Africa Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Biopharmaceutical CMO Market Competitive Landscape And Company Profiles

    27.1. Biopharmaceutical CMO Market Competitive Landscape

    27.2. Biopharmaceutical CMO Market Company Profiles

    27.2.1. Lonza Group AG

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Fujifilm Diosynth Biotechnologies U.S.A., Inc

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Thermo Fisher Scientific, Inc

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Samsung BioLogics

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. WuXi Biologics

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Biopharmaceutical CMO Market

    29. Biopharmaceutical CMO Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Biopharmaceutical CMO Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Biopharmaceutical CMO Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Lonza Group AG Financial Performance
  • Table 47: Fujifilm Diosynth Biotechnologies U.S.A., Inc Financial Performance
  • Table 48: Thermo Fisher Scientific, Inc Financial Performance
  • Table 49: Samsung BioLogics Financial Performance
  • Table 50: WuXi Biologics Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Biopharmaceutical CMO Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Biopharmaceutical CMO Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Lonza Group AG Financial Performance
  • Figure 47: Fujifilm Diosynth Biotechnologies U.S.A., Inc Financial Performance
  • Figure 48: Thermo Fisher Scientific, Inc Financial Performance
  • Figure 49: Samsung BioLogics Financial Performance
  • Figure 50: WuXi Biologics Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report